Evidence map›Paper›PMID 25889767›Full record

ArticleMalaria journal2015

Are Tanzanian patients attending public facilities or private retailers more likely to adhere to artemisinin-based combination therapy?

Katia Bruxvoort, Admirabilis Kalolella, Matthew Cairns, Charles Festo, Mitya Kenani, Peter Lyaruu, S Patrick Kachur, David Schellenberg, Catherine Goodman

Open access · goldAbstract read
In one paragraph

Article in Malaria journal, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Article
  9. Article
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

Katia BruxvoortLondon School of Hygiene and Tropical Medicine, London, UK. katia.bruxvoort@lshtm.ac.uk.
Admirabilis KalolellaIfakara Health Institute, Dar es Salaam, Tanzania. akalolella@ihi.or.tz.
Matthew CairnsLondon School of Hygiene and Tropical Medicine, London, UK. matthew.cairns@lshtm.ac.uk.
Charles FestoIfakara Health Institute, Dar es Salaam, Tanzania. cfesto@ihi.or.tz.
Mitya KenaniIfakara Health Institute, Dar es Salaam, Tanzania. mityamillie@yahoo.com.
Peter LyaruuIfakara Health Institute, Dar es Salaam, Tanzania. piere.lyaruu@yahoo.com.
S Patrick KachurMalaria Branch, Centers for Disease Control and Prevention, Atlanta, USA. spk0@cdc.gov.
David SchellenbergLondon School of Hygiene and Tropical Medicine, London, UK. david.schellenberg@lshtm.ac.uk.
Catherine GoodmanLondon School of Hygiene and Tropical Medicine, London, UK. catherine.goodman@lshtm.ac.uk.
Ifakara Health Institute · TZLondon School of Hygiene & Tropical Medicine · GBCenters for Disease Control and Prevention · US

Funding

Medical Research Council MR/J012394/1Medical Research Council MR/K012126/1
6 · The paper itself

Abstract

backgroundArtemisinin combination therapy (ACT) is first-line treatment for malaria in most endemic countries and is increasingly available in the private sector. Most studies on ACT adherence have been conducted in the public sector, with minimal data from private retailers.

methodsParallel studies were conducted in Tanzania, in which patients obtaining artemether-lumefantrine (AL) at 40 randomly selected public health facilities and 37 accredited drug dispensing outlets (ADDOs) were visited at home and questioned about doses taken. The effect of sector on adherence, controlling for potential confounders was assessed using logistic regression with a random effect for outlet.

resultsOf 572 health facility patients and 450 ADDO patients, 74.5% (95% CI: 69.8, 78.8) and 69.8% (95% CI: 64.6, 74.5), respectively, completed treatment and 46.0% (95% CI: 40.9, 51.2) and 34.8% (95% CI: 30.1, 39.8) took each dose at the correct time ('timely completion'). ADDO patients were wealthier, more educated, older, sought care later in the day, and were less likely to test positive for malaria than health facility patients. Controlling for patient characteristics, the adjusted odds of completed treatment and of timely completion for ADDO patients were 0.65 (95% CI: 0.43, 1.00) and 0.69 (95% CI: 0.47, 1.01) times that of health facility patients. Higher socio-economic status was associated with both adherence measures. Higher education was associated with completed treatment (adjusted OR = 1.68, 95% CI: 1.20, 2.36); obtaining AL in the evening was associated with timely completion (adjusted OR = 0.35, 95% CI: 0.19, 0.64). Factors associated with adherence in each sector were examined separately. In both sectors, recalling correct instructions was positively associated with both adherence measures. In health facility patients, but not ADDO patients, taking the first dose of AL at the outlet was associated with timely completion (adjusted OR = 2.11, 95% CI: 1.46, 3.04).

conclusionWhen controlling for patient characteristics, there was some evidence that the adjusted odds of adherence for ADDO patients was lower than that for public health facility patients. Better understanding is needed of which patient care aspects are most important for adherence, including the role of effective provision of advice.

Indexed as

AdolescentAntimalarialsArtemisininsChildChild, PreschoolDrug Therapy, CombinationFemaleHumansInfantInfant, NewbornMalePatient CompliancePrivate SectorPublic SectorTanzaniaAntimalarialsartemisininArtemisinins

Identifiers

PMID25889767
PMCPMC4340668
OpenAlexW2141398594

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.